{
    "@graph": [
        {
            "@id": "gnd:1220929808",
            "sameAs": "Pietzsch, Markus"
        },
        {
            "@id": "gnd:1241830266",
            "sameAs": "Fritz, Claudia"
        },
        {
            "@id": "gnd:129366366",
            "sameAs": "Schilling, Stephan"
        },
        {
            "@id": "gnd:2024276-1",
            "sameAs": "Martin-Luther-Universit\u00e4t Halle-Wittenberg"
        },
        {
            "@id": "https://www.tib.eu/de/suchen/id/TIBKAT%3A1776311930",
            "@type": "bibo:Thesis",
            "P1053": "1 Online-Ressource (179 Seiten)",
            "http://purl.org/dc/elements/1.1/contributor": "St\u00f6cker, Walter",
            "description": "Illustrationen, Diagramme",
            "identifier": [
                "(firstid)KXP:1776311930",
                "(doi)10.25673/39255",
                "(ppn)1776311930"
            ],
            "subject": [
                "(classificationName=ddc-dbn)610",
                "(classificationName=ddc-dbn)570",
                "(classificationName=ddc)572.7",
                "(classificationName=linseach:mapping)bio",
                "(classificationName=linseach:mapping)meda"
            ],
            "title": "On the 3D-structures of Meprin \u03b1 and \u03b2, and the role of oligomerization for stability and activity of Meprin \u03b1",
            "abstract": [
                "Die Isoenzyme Meprin \u03b1 und Meprin \u03b2 repr\u00e4sentieren Multidom\u00e4nen-Metalloproteasen der Astacin-Familie. W\u00e4hrend Meprin \u03b2 membranst\u00e4ndig ist, wird Meprin \u03b1 in den extrazellul\u00e4ren Raum sezerniert. Dies f\u00fchrt zur Oligomerisierung von Meprin \u03b1-Dimeren durch nicht-kovalente Interaktionen. Aufgrund ihrer Substratspezifit\u00e4t werden Meprine mit verschiedenen pathologischen Zust\u00e4nden assoziiert z.B. Fibrose, Nephritis oder neurogenerativen Erkrankungen. Folglich sind diese Proteasen im Fokus der Wirkstoffforschung und selektive Inhibitoren wurden bereits entwickelt. Zur weiteren Wirkstoffoptimierung sind die 3DStrukturen der Meprine in Komplex mit ihren spezifischen Inhibitoren entscheidend und werden in dieser Arbeit pr\u00e4sentiert. Mittels R\u00f6ntgenkristallographie und Kryo-Elektronen Mikroskopie (single particle analysis) wurden zwei 3D-Strukturen von Meprin \u03b2 in Komplex mit einem selektiven Inhibitor zu einer Aufl\u00f6sung von 2,41 \u00c5 und 3,0 \u00c5 aufgekl\u00e4rt. Erstmals konnte die 3D-Struktur von Meprin \u03b1 in Komplex mit einem spezifischen Inhibitor dargestellt werden (2,42 \u00c5). Zus\u00e4tzlich wurden die strukturellen Faktoren der Oligomerisierung von Meprin \u03b1 identifiziert. Die helikalen Oligomere sind durch elektrostatische Wechselwirkungen zwischen Aminos\u00e4uren der MAM- und TRAF-Dom\u00e4nen von dimeren Meprin \u03b1 Molek\u00fclen stabilisiert. Der Einfluss der Oligomerisierung von Meprin \u03b1 auf die Stabilit\u00e4t und Aktivit\u00e4t der Protease wurde ebenfalls untersucht und in dieser Arbeit diskutiert.",
                "Meprin alpha, Meprin beta, Metalloprotease, Astacin, R\u00f6ntgenkristallographie, Kryo-Elektronen Mikroskopie, Metalloproteaseinhibitoren, Proteinstruktur, Fibrose, Nephritis",
                "Meprin alpha, Meprin beta, metalloproteinase, astacin, X-ray crystallography, cryo-electron microscopy, metalloproteinase inhibition, protein structure, Fibrosis, Nephritis",
                "The isoenzymes Meprin \u03b1 and Meprin \u03b2 represent multidomain metalloproteases of the astacin family. Whereas Meprin \u03b2 is tethered to the membrane, Meprin \u03b1 is released into the extracellular space. Upon shedding from the membrane, Meprin \u03b1 oligomers up to the Mega-Dalton range are formed by non-covalent interactions between Meprin \u03b1 dimers. Driven by their substrate cleavage specificity, Meprins are key players in fibrosis and keloids, but also in nephritis and neurodegeneration. Consequently, Meprin \u03b1 and Meprin \u03b2 are within focus of current drug discovery and selective inhibitors were developed. For further drug design and optimization, the 3D-structures of Meprins in complex with specific inhibitors were elucidated and are presented within the present study. Using the structural elucidation approaches X-ray crystallography and cryo-electron microscopy single particle analysis two 3D-structures of Meprin \u03b2 in complex with its specific inhibitor were elucidated to a resolution of 2.41 \u00c5 and 3.0 \u00c5, respectively. For the first time the structure of mature Meprin \u03b1 in complex with its specific inhibitor was elucidated to a resolution of 2.42 \u00c5 using cryo-EM single particle analysis. Moreover, the structural determinants for oligomerization of Meprin \u03b1 were identified. It turned out that the helical particles are stabilized by electrostatic interactions within the MAM and TRAF domains of dimeric Meprin \u03b1 molecules. The impact of the oligomerization of Meprin \u03b1 on its stability and activity in comparison to non-oligomerizing variants of Meprin \u03b1 (C308A, R372T) was examined within the present study, as well."
            ],
            "contributor": [
                "gnd:129366366",
                "gnd:1220929808"
            ],
            "dcterms:contributor": "Technische Informationsbibliothek (TIB)",
            "creator": [
                "gnd:2024276-1",
                "gnd:1241830266"
            ],
            "isPartOf": [
                "(collectioncode)GBV-BASE-ODISS",
                "(collectioncode)GBV-ODiss"
            ],
            "issued": "2021",
            "language": "http://id.loc.gov/vocabulary/iso639-1/en",
            "license": "open access",
            "medium": "rda:termList/RDACarrierType/1018",
            "isLike": "doi:10.25673/39255",
            "P60163": "Halle"
        }
    ],
    "@id": "urn:x-arq:DefaultGraphNode",
    "@context": {
        "sameAs": "http://www.w3.org/2002/07/owl#sameAs",
        "contributor": {
            "@id": "http://purl.org/dc/terms/contributor",
            "@type": "@id"
        },
        "issued": "http://purl.org/dc/terms/issued",
        "description": "http://purl.org/dc/elements/1.1/description",
        "abstract": "http://purl.org/dc/terms/abstract",
        "P1053": "http://iflastandards.info/ns/isbd/elements/P1053",
        "subject": "http://purl.org/dc/elements/1.1/subject",
        "identifier": "http://purl.org/dc/elements/1.1/identifier",
        "creator": {
            "@id": "http://purl.org/dc/terms/creator",
            "@type": "@id"
        },
        "title": "http://purl.org/dc/elements/1.1/title",
        "isPartOf": "http://purl.org/dc/terms/isPartOf",
        "medium": {
            "@id": "http://purl.org/dc/terms/medium",
            "@type": "@id"
        },
        "license": "http://purl.org/dc/terms/license",
        "language": {
            "@id": "http://purl.org/dc/terms/language",
            "@type": "@id"
        },
        "P60163": "http://www.rdaregistry.info/Elements/u/#P60163",
        "isLike": {
            "@id": "http://umbel.org/umbel#isLike",
            "@type": "@id"
        },
        "umbel": "http://umbel.org/umbel#",
        "rdau": "http://www.rdaregistry.info/Elements/u/#",
        "owl": "http://www.w3.org/2002/07/owl#",
        "dcterms": "http://purl.org/dc/terms/",
        "bibo": "http://purl.org/ontology/bibo/",
        "rdam": "http://www.rdaregistry.info/Elements/m/#",
        "gnd": "http://d-nb.info/gnd/",
        "isbd": "http://iflastandards.info/ns/isbd/elements/",
        "rda": "http://rdvocab.info/",
        "doi": "https://doi.org/"
    }
}